Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:26598643

Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins.

Marcus Hoffmann · Kristina Marx · Udo Reichl · Manfred Wuhrer · Erdmann Rapp

Molecular & cellular proteomics : MCP · 2016 doi:10.1074/mcp.M115.053546

Paper

complete

Experiment

partial

Data

partial

Analysis

absent

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:26598643
kind
science-record
content_hash
sha256:497d081d4ba6cfc1cc0c39d4e7e128fc7890814232520212e5e8393935e7ff5f
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:14Z
updated_at
2026-11-01T18:47:48Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins.
doi
10.1074/mcp.M115.053546
pmid
26598643
authors array · 5 items
[0]
Marcus Hoffmann
[1]
Kristina Marx
[2]
Udo Reichl
[3]
Manfred Wuhrer
[4]
Erdmann Rapp
journal
Molecular & cellular proteomics : MCP
year
2016
abstract
Site-specific glycosylation analysis is key to investigate structure-function relationships of glycoproteins, e.g. in the context of antigenicity and disease progression. The analysis, though, is quite challenging and time consuming, in particular for O-glycosylated proteins. In consequence, despite their clinical and biopharmaceutical importance, many human blood plasma glycoproteins have not been characterized comprehensively with respect to their O-glycosylation. Here, we report on the site-specific O-glycosylation analysis of human blood plasma glycoproteins. To this end pooled human blood plasma of healthy donors was proteolytically digested using a broad-specific enzyme (Proteinase K), followed by a precipitation step, as well as a glycopeptide enrichment and fractionation step via hydrophilic interaction liquid chromatography, the latter being optimized for intact O-glycopeptides carrying short mucin-type core-1 and -2 O-glycans, which represent the vast majority of O-glycans on human blood plasma proteins. Enriched O-glycopeptide fractions were subjected to mass spectrometric analysis using reversed-phase liquid chromatography coupled online to an ion trap mass spectrometer operated in positive-ion mode. Peptide identity and glycan composition were derived from low-energy collision-induced dissociation fragment spectra acquired in multistage mode. To pinpoint the O-glycosylation sites glycopeptides were fragmented using electron transfer dissociation. Spectra were annotated by database searches as well as manually. Overall, 31 O-glycosylation sites and regions belonging to 22 proteins were identified, the majority being acute-phase proteins. Strikingly, also 11 novel O-glycosylation sites and regions were identified. In total 23 O-glycosylation sites could be pinpointed. Interestingly, the use of Proteinase K proved to be particularly beneficial in this context. The identified O-glycan compositions most probably correspond to mono- and disialylated core-1 mucin-type O-glycans (T-antigen). The developed workflow allows the identification and characterization of the major population of the human blood plasma O-glycoproteome and our results provide new insights, which can help to unravel structure-function relationships. The data were deposited to ProteomeXchange PXD003270.
claims array · 1 item
[0] object · 6 fields
id
claim-data-access
statement
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:26598643
locator
sections[15] "Analysis of Glycopeptides" paragraph 5
quote
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:26598643
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_unresolved
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD002315
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD002315
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_unresolved
data object · 3 fields
state
partial
assets array · 5 items
[0] object · 15 fields
id
source:pmid:26598643
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1074/mcp.M115.053546
sha256
sha256:faebdaae44b098ebe51f69d0ebafb852b26258a05bd59dd8e80ca846d675e354
bytes
77244
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1074/mcp.M115.053546
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC4739677
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD002315
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD002315
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD002315
version
null
note
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
null
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:PXD003270
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD003270
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD003270
version
null
note
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
null
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[3] object · 16 fields
id
asset:table:pmid:26598643:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:4fa80e3150e545c3b70f3e358d37449c619961da1305fcb8eb5c46a0c56b67f0
bytes
1138
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[22]/table-wrap[1]#TI
version
null
note
Site-specific O-glycan composition of identified human blood plasma glycoproteins. Glycoproteins are listed with their UniprotKB accession number as well as the number of identified glycopeptides. O-glycosylated sites or regions are indexed with respect to the attached O-glycans (mono- and/or disialylated mucin-type core 1 O-glycans). O-glycosylation sites in bold have been pinpointed within this study. Previously unknown sites und regions are indicated by underlining. Curled brackets mark regions with several possible O-glycosylation sites. Superscript numbers indicate literature references. For every protein the number of registered, previously known, as well as new O-glycosylation sites and regions are given. For underlined proteins, glycosylated as well as non-glycosylated peptides were identified (supplemental Table S1). In addition previously reported plasma concentrations are given. HexNAc (N-acetylhexosamine), Hex (hexose), NeuAc (N-acetylneuraminic acid, sialic acid)
structure object · 5 fields
pmcid
PMC4739677
section_index
22
section_title
Identification of the Peptide Moiety
row_count
0
column_count
0
table object · 8 fields
label
Table I
caption
Site-specific O-glycan composition of identified human blood plasma glycoproteins. Glycoproteins are listed with their UniprotKB accession number as well as the number of identified glycopeptides. O-glycosylated sites or regions are indexed with respect to the attached O-glycans (mono- and/or disialylated mucin-type core 1 O-glycans). O-glycosylation sites in bold have been pinpointed within this study. Previously unknown sites und regions are indicated by underlining. Curled brackets mark regions with several possible O-glycosylation sites. Superscript numbers indicate literature references. For every protein the number of registered, previously known, as well as new O-glycosylation sites and regions are given. For underlined proteins, glycosylated as well as non-glycosylated peptides were identified (supplemental Table S1). In addition previously reported plasma concentrations are given. HexNAc (N-acetylhexosamine), Hex (hexose), NeuAc (N-acetylneuraminic acid, sialic acid)
rows array · 0 items
locator
section[22]/table-wrap[1]#TI
[4] object · 16 fields
id
asset:table:pmid:26598643:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:b6a8999edea25a8e13e1d469130b3772aafa643d482ed56d691ba16dedb19912
bytes
826
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[22]/table-wrap[2]#TII
version
null
note
Detailed overview of all identified human blood plasma O-glycopeptides. For each O-glycopeptide, the corresponding glycoprotein including the UniProtKB accession number, the identified O-glycosylation site(s)/regions as well as the O-glycan composition are given, respectively. Likewise, the LC-MS retention time, the mass of the intact glycopeptide precursor, the measured peptide mass as well as the corresponding error is listed. The peptide identification using CID-MS3 was validated by the MASCOT peptide score and the Biotools score (CID). ETD based determination of the O-glycosylation site(s) was validated by the Biotools score (CID) as well as the NetOGlyc 4.0 score
structure object · 5 fields
pmcid
PMC4739677
section_index
22
section_title
Identification of the Peptide Moiety
row_count
0
column_count
0
table object · 8 fields
label
Table II
caption
Detailed overview of all identified human blood plasma O-glycopeptides. For each O-glycopeptide, the corresponding glycoprotein including the UniProtKB accession number, the identified O-glycosylation site(s)/regions as well as the O-glycan composition are given, respectively. Likewise, the LC-MS retention time, the mass of the intact glycopeptide precursor, the measured peptide mass as well as the corresponding error is listed. The peptide identification using CID-MS3 was validated by the MASCOT peptide score and the Biotools score (CID). ETD based determination of the O-glycosylation site(s) was validated by the Biotools score (CID) as well as the NetOGlyc 4.0 score
rows array · 0 items
locator
section[22]/table-wrap[2]#TII
gaps array · 4 items
[0]
asset:data:geo:PXD002315 not downloaded
[1]
asset:data:geo:PXD002315 licence not read
[2]
asset:data:geo:PXD003270 not downloaded
[3]
asset:data:geo:PXD003270 licence not read
analysis object · 4 fields
state
absent
methods array · 0 items
targets array · 0 items
gaps array · 2 items
[0]
method
[1]
operations
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (not named), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 2 items
[0]
PXD003270
[1]
PXD002315
resolved_accessions array · 0 items
statements array · 1 item
[0]
All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.
basis
The paper names PXD003270, PXD002315, but the accession does not resolve in the repository (not_in_proteomexchange, not_in_proteomexchange), so the data cannot be reached from here. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 4 items
[0]
source:pmid:26598643
[1]
data:geo:PXD002315
[2]
asset:table:pmid:26598643:1
[3]
asset:table:pmid:26598643:2
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD002315
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:06:37Z
independence
same_provider
evidence_check object · 2 fields
method
null
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
57250
completion_tokens
1056
cached_tokens
520
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:26598643
type
paper
label
pmid:26598643
[1] object · 3 fields
id
source:pmid:26598643
type
manuscript
label
PMID 26598643 full text
[2] object · 3 fields
id
data:geo:PXD002315
type
dataset
label
GEO PXD002315
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:26598643
type
paper
label
pmid:26598643
[1] object · 3 fields
id
source:pmid:26598643
type
manuscript
label
PMID 26598643 full text
[2] object · 3 fields
id
data:geo:PXD002315
type
dataset
label
GEO PXD002315
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-26598643
type
extraction
used array · 1 item
[0]
source:pmid:26598643
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD002315
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD002315
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:26598643
parent_hash
sha256:aa9f68b23f5ae0bec77a66a41c6975f37af05fb68f557351f8997170e638a7ea
fork_of
null
gaps array · 11 items
[0]
asset:data:geo:PXD002315 licence not read
[1]
asset:data:geo:PXD002315 not downloaded
[2]
asset:data:geo:PXD003270 licence not read
[3]
asset:data:geo:PXD003270 not downloaded
[4]
execution.not_run
[5]
method
[6]
operations
[7]
review.human_critique
[8]
review.independent_reader
[9]
review.machine_critique
[10]
step:obtain_source_data blocked on data:accession_unresolved
assays array · 1 item
[0] object · 11 fields
role
data_generation
definition_id
mass_spectrometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
d O-glycopeptide fractions were subjected to mass spectrometric analysis using reversed-phase liquid chromat
[1]
n; ETD = Electron transfer dissociation. All mass spectrometry raw data as well as (glyco)peptide identific
order_basis
paper_text_order:1108
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:26598643", "kind": "science-record", "revision": 5, "content_hash": "sha256:497d081d4ba6cfc1cc0c39d4e7e128fc7890814232520212e5e8393935e7ff5f", "created_at": "2026-11-01T15:40:14Z", "updated_at": "2026-11-01T18:47:48Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins.", "doi": "10.1074/mcp.M115.053546", "pmid": "26598643", "authors": ["Marcus Hoffmann", "Kristina Marx", "Udo Reichl", "Manfred Wuhrer", "Erdmann Rapp"], "journal": "Molecular & cellular proteomics : MCP", "year": 2016, "abstract": "Site-specific glycosylation analysis is key to investigate structure-function relationships of glycoproteins, e.g. in the context of antigenicity and disease progression. The analysis, though, is quite challenging and time consuming, in particular for O-glycosylated proteins. In consequence, despite their clinical and biopharmaceutical importance, many human blood plasma glycoproteins have not been characterized comprehensively with respect to their O-glycosylation. Here, we report on the site-specific O-glycosylation analysis of human blood plasma glycoproteins. To this end pooled human blood plasma of healthy donors was proteolytically digested using a broad-specific enzyme (Proteinase K), followed by a precipitation step, as well as a glycopeptide enrichment and fractionation step via hydrophilic interaction liquid chromatography, the latter being optimized for intact O-glycopeptides carrying short mucin-type core-1 and -2 O-glycans, which represent the vast majority of O-glycans on human blood plasma proteins. Enriched O-glycopeptide fractions were subjected to mass spectrometric analysis using reversed-phase liquid chromatography coupled online to an ion trap mass spectrometer operated in positive-ion mode. Peptide identity and glycan composition were derived from low-energy collision-induced dissociation fragment spectra acquired in multistage mode. To pinpoint the O-glycosylation sites glycopeptides were fragmented using electron transfer dissociation. Spectra were annotated by database searches as well as manually. Overall, 31 O-glycosylation sites and regions belonging to 22 proteins were identified, the majority being acute-phase proteins. Strikingly, also 11 novel O-glycosylation sites and regions were identified. In total 23 O-glycosylation sites could be pinpointed. Interestingly, the use of Proteinase K proved to be particularly beneficial in this context. The identified O-glycan compositions most probably correspond to mono- and disialylated core-1 mucin-type O-glycans (T-antigen). The developed workflow allows the identification and characterization of the major population of the human blood plasma O-glycoproteome and our results provide new insights, which can help to unravel structure-function relationships. The data were deposited to ProteomeXchange PXD003270.", "claims": [{"id": "claim-data-access", "statement": "All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:26598643", "locator": "sections[15] \"Analysis of Glycopeptides\" paragraph 5", "quote": "All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:26598643"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_unresolved", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD002315"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD002315"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_unresolved"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:26598643", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1074/mcp.M115.053546", "sha256": "sha256:faebdaae44b098ebe51f69d0ebafb852b26258a05bd59dd8e80ca846d675e354", "bytes": 77244, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1074/mcp.M115.053546", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC4739677", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD002315", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD002315", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD002315", "version": null, "note": "All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": null, "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:PXD003270", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD003270", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD003270", "version": null, "note": "All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": null, "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:26598643:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:4fa80e3150e545c3b70f3e358d37449c619961da1305fcb8eb5c46a0c56b67f0", "bytes": 1138, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[22]/table-wrap[1]#TI", "version": null, "note": "Site-specific O-glycan composition of identified human blood plasma glycoproteins. Glycoproteins are listed with their UniprotKB accession number as well as the number of identified glycopeptides. O-glycosylated sites or regions are indexed with respect to the attached O-glycans (mono- and/or disialylated mucin-type core 1 O-glycans). O-glycosylation sites in bold have been pinpointed within this study. Previously unknown sites und regions are indicated by underlining. Curled brackets mark regions with several possible O-glycosylation sites. Superscript numbers indicate literature references. For every protein the number of registered, previously known, as well as new O-glycosylation sites and regions are given. For underlined proteins, glycosylated as well as non-glycosylated peptides were identified (supplemental Table S1). In addition previously reported plasma concentrations are given. HexNAc (N-acetylhexosamine), Hex (hexose), NeuAc (N-acetylneuraminic acid, sialic acid)", "structure": {"pmcid": "PMC4739677", "section_index": 22, "section_title": "Identification of the Peptide Moiety", "row_count": 0, "column_count": 0}, "table": {"label": "Table I", "caption": "Site-specific O-glycan composition of identified human blood plasma glycoproteins. Glycoproteins are listed with their UniprotKB accession number as well as the number of identified glycopeptides. O-glycosylated sites or regions are indexed with respect to the attached O-glycans (mono- and/or disialylated mucin-type core 1 O-glycans). O-glycosylation sites in bold have been pinpointed within this study. Previously unknown sites und regions are indicated by underlining. Curled brackets mark regions with several possible O-glycosylation sites. Superscript numbers indicate literature references. For every protein the number of registered, previously known, as well as new O-glycosylation sites and regions are given. For underlined proteins, glycosylated as well as non-glycosylated peptides were identified (supplemental Table S1). In addition previously reported plasma concentrations are given. HexNAc (N-acetylhexosamine), Hex (hexose), NeuAc (N-acetylneuraminic acid, sialic acid)", "rows": [], "row_count": 0, "column_count": 0, "numeric_cells": 0, "header_rows": 0, "locator": "section[22]/table-wrap[1]#TI"}}, {"id": "asset:table:pmid:26598643:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:b6a8999edea25a8e13e1d469130b3772aafa643d482ed56d691ba16dedb19912", "bytes": 826, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[22]/table-wrap[2]#TII", "version": null, "note": "Detailed overview of all identified human blood plasma O-glycopeptides. For each O-glycopeptide, the corresponding glycoprotein including the UniProtKB accession number, the identified O-glycosylation site(s)/regions as well as the O-glycan composition are given, respectively. Likewise, the LC-MS retention time, the mass of the intact glycopeptide precursor, the measured peptide mass as well as the corresponding error is listed. The peptide identification using CID-MS3 was validated by the MASCOT peptide score and the Biotools score (CID). ETD based determination of the O-glycosylation site(s) was validated by the Biotools score (CID) as well as the NetOGlyc 4.0 score", "structure": {"pmcid": "PMC4739677", "section_index": 22, "section_title": "Identification of the Peptide Moiety", "row_count": 0, "column_count": 0}, "table": {"label": "Table II", "caption": "Detailed overview of all identified human blood plasma O-glycopeptides. For each O-glycopeptide, the corresponding glycoprotein including the UniProtKB accession number, the identified O-glycosylation site(s)/regions as well as the O-glycan composition are given, respectively. Likewise, the LC-MS retention time, the mass of the intact glycopeptide precursor, the measured peptide mass as well as the corresponding error is listed. The peptide identification using CID-MS3 was validated by the MASCOT peptide score and the Biotools score (CID). ETD based determination of the O-glycosylation site(s) was validated by the Biotools score (CID) as well as the NetOGlyc 4.0 score", "rows": [], "row_count": 0, "column_count": 0, "numeric_cells": 0, "header_rows": 0, "locator": "section[22]/table-wrap[2]#TII"}}], "gaps": ["asset:data:geo:PXD002315 not downloaded", "asset:data:geo:PXD002315 licence not read", "asset:data:geo:PXD003270 not downloaded", "asset:data:geo:PXD003270 licence not read"]}, "analysis": {"state": "absent", "methods": [], "targets": [], "gaps": ["method", "operations"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (not named), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": ["PXD003270", "PXD002315"], "resolved_accessions": [], "statements": ["All mass spectrometry raw data as well as (glyco)peptide identifications and spectra annotations have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)via the MassIVE repository with the dataset identifier PXD002315or MSV000079141, respectively."], "basis": "The paper names PXD003270, PXD002315, but the accession does not resolve in the repository (not_in_proteomexchange, not_in_proteomexchange), so the data cannot be reached from here. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:26598643", "data:geo:PXD002315", "asset:table:pmid:26598643:1", "asset:table:pmid:26598643:2"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD002315"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:06:37Z", "independence": "same_provider"}, "evidence_check": {"method": null, "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 57250, "completion_tokens": 1056, "cached_tokens": 520}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:26598643", "type": "paper", "label": "pmid:26598643"}, {"id": "source:pmid:26598643", "type": "manuscript", "label": "PMID 26598643 full text"}, {"id": "data:geo:PXD002315", "type": "dataset", "label": "GEO PXD002315"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:26598643", "type": "paper", "label": "pmid:26598643"}, {"id": "source:pmid:26598643", "type": "manuscript", "label": "PMID 26598643 full text"}, {"id": "data:geo:PXD002315", "type": "dataset", "label": "GEO PXD002315"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-26598643", "type": "extraction", "used": ["source:pmid:26598643"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD002315", "type": "accession_resolution", "used": ["data:geo:PXD002315"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:26598643", "parent_hash": "sha256:aa9f68b23f5ae0bec77a66a41c6975f37af05fb68f557351f8997170e638a7ea", "fork_of": null, "generation": 4}, "gaps": ["asset:data:geo:PXD002315 licence not read", "asset:data:geo:PXD002315 not downloaded", "asset:data:geo:PXD003270 licence not read", "asset:data:geo:PXD003270 not downloaded", "execution.not_run", "method", "operations", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_unresolved"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["d O-glycopeptide fractions were subjected to mass spectrometric analysis using reversed-phase liquid chromat", "n; ETD = Electron transfer dissociation. All mass spectrometry raw data as well as (glyco)peptide identific"], "order_basis": "paper_text_order:1108", "id": "assay:1"}]}